KOPRANNSEKopran Limited· PharmaceuticalsMediumNeutral
Announced Thu, 7 May · 16:21 IST

Kopran Limited has informed the Exchange about Shareholders meeting

Board & Shareholder Meetings View source PDF

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.1%1-day move
₹165.38
prior close
₹164.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.4+0.6+0.0-4.1-8.9-6.5-5.4-6.0+2.4+18.5+10.0+10.7
Up moveDown movePending
AI summary

Kopran Limited is convening a shareholders meeting on June 3, 2026 via video conferencing to seek approval for the amalgamation of Kopran Laboratories Limited (KLL) into Kopran Limited. The merger will increase promoter holding from 44.43% to 55.33%, reducing public shareholding from 55.57% to 44.67%. BSE and NSE have issued no-objection letters for this scheme. Remote e-voting runs from May 27 to June 2, 2026. The company states the impact on public shareholders' rights and value is NIL. The scheme requires approval by 3/4th majority of shareholders voting and a majority of public shareholders voting in favour.

Likely market impact

This is a standard pharma sector consolidation. Promoter holding will cross 55%, giving them stronger control. The company maintains there is no value dilution for public shareholders, though their percentage ownership will decrease by nearly 11 percentage points.